Ercros (ECR) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.130x

Based on the latest financial reports, Ercros (ECR) has a cash flow conversion efficiency ratio of 0.130x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€38.91 Million ≈ $45.49 Million USD) by net assets (€298.23 Million ≈ $348.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Ercros (ECR) liquidity interval to measure how many days the company can operate on defensive assets alone.

Ercros - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Ercros's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Ercros Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ercros ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
i3system Inc
KQ:214430
0.073x
Accent Group Ltd
AU:AX1
0.214x
Regenxbio Inc
NASDAQ:RGNX
-3.614x
BLD Plantation Bhd
KLSE:5069
0.136x
Jiangsu Nanfang Medical
SHG:603880
0.071x
Dogus Gayrimenkul Yatirim Ortakligi AS
IS:DGGYO
0.005x
Bell Financial Group Ltd
AU:BFG
0.188x
Regional Management Corp
NYSE:RM
0.216x

Annual Cash Flow Conversion Efficiency for Ercros (2004–2025)

The table below shows the annual cash flow conversion efficiency of Ercros from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see Ercros (ECR) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €298.23 Million
≈ $348.66 Million
€49.19 Million
≈ $57.51 Million
0.165x +491.42%
2024-12-31 €341.16 Million
≈ $398.85 Million
€9.51 Million
≈ $11.12 Million
0.028x -80.20%
2023-12-31 €363.12 Million
≈ $424.52 Million
€51.14 Million
≈ $59.79 Million
0.141x -19.35%
2022-12-31 €360.71 Million
≈ $421.71 Million
€62.99 Million
≈ $73.64 Million
0.175x -4.01%
2021-12-31 €331.61 Million
≈ $387.69 Million
€60.32 Million
≈ $70.53 Million
0.182x -30.69%
2020-12-31 €284.21 Million
≈ $332.28 Million
€74.59 Million
≈ $87.20 Million
0.262x +28.98%
2019-12-31 €292.08 Million
≈ $341.48 Million
€59.43 Million
≈ $69.48 Million
0.203x +23.63%
2018-12-31 €272.67 Million
≈ $318.78 Million
€44.88 Million
≈ $52.46 Million
0.165x -7.03%
2017-12-31 €247.49 Million
≈ $289.34 Million
€43.81 Million
≈ $51.22 Million
0.177x -0.09%
2016-12-31 €219.83 Million
≈ $257.00 Million
€38.95 Million
≈ $45.54 Million
0.177x +122.59%
2015-12-31 €175.88 Million
≈ $205.62 Million
€14.00 Million
≈ $16.37 Million
0.080x -52.27%
2014-12-31 €168.19 Million
≈ $196.63 Million
€28.05 Million
≈ $32.79 Million
0.167x +20.37%
2013-12-31 €172.21 Million
≈ $201.33 Million
€23.86 Million
≈ $27.89 Million
0.139x +25.67%
2012-12-31 €173.87 Million
≈ $203.27 Million
€19.17 Million
≈ $22.41 Million
0.110x +79.08%
2011-12-31 €187.11 Million
≈ $218.75 Million
€11.52 Million
≈ $13.47 Million
0.062x +211.86%
2010-12-31 €192.23 Million
≈ $224.74 Million
€-10.58 Million
≈ $-12.37 Million
-0.055x -127.63%
2009-12-31 €205.38 Million
≈ $240.11 Million
€40.91 Million
≈ $47.83 Million
0.199x +107.53%
2008-12-31 €257.20 Million
≈ $300.69 Million
€-680.00 Million
≈ $-794.99 Million
-2.644x -3972.47%
2007-12-31 €463.14 Million
≈ $541.46 Million
€31.62 Million
≈ $36.97 Million
0.068x +269.03%
2006-12-31 €359.97 Million
≈ $420.84 Million
€-14.54 Million
≈ $-17.00 Million
-0.040x -1477.60%
2005-12-31 €253.87 Million
≈ $296.80 Million
€-650.00K
≈ $-759.92K
-0.003x +98.43%
2004-12-31 €95.06 Million
≈ $111.14 Million
€-15.51 Million
≈ $-18.13 Million
-0.163x --

About Ercros

MC:ECR Spain Chemicals
Market Cap
$370.40 Million
€316.83 Million EUR
Market Cap Rank
#14652 Global
#92 in Spain
Share Price
€3.47
Change (1 day)
+0.14%
52-Week Range
€2.24 - €3.48
All Time High
€4.83
About

Ercros, S.A., together with its subsidiaries, manufactures and sells chemical and pharmaceutical products in Spain and internationally. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmaceuticals. The company offers ammonia, caustic soda and potash, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl ch… Read more